Ballew Advisors, Inc Merck & Co., Inc. Transaction History

Ballew Advisors, Inc

$146 Million
Q3 2024

A detailed history of Ballew Advisors, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ballew Advisors, Inc holds 3,153 shares of MRK stock, worth $325,137. This represents 0.24% of its overall portfolio holdings.

Number of Shares

3,153

Previous 3,050 3.38%

Holding current value

$325,137

Previous $377,000 5.04%

% of portfolio

0.24%

Previous 0.27%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$111.15 - $128.97 $11,448 - $13,283	103 Added 3.38%	3,153 $358,000
Q2 2024 Jul 17, 2024	BUY	$123.8 - $132.96 $1,857 - $1,994	15 Added 0.49%	3,050 $377,000
Q1 2024 Apr 11, 2024	BUY	$113.24 - $131.95 $1,585 - $1,847	14 Added 0.46%	3,035 $400,000
Q4 2023 Jan 18, 2024	SELL	$100.18 - $109.02 $11,019 - $11,992	-110 Reduced 3.51%	3,021 $329,000
Q2 2023 Jul 20, 2023	BUY	$108.61 - $118.38 $1,629 - $1,775	15 Added 0.48%	3,131 $361,000
Q1 2023 Jul 06, 2023	BUY	$102.94 - $114.86 $11,941 - $13,323	116 Added 3.87%	3,116 $331,000
Q4 2022 Jan 13, 2023	BUY	$87.44 - $112.11 $1,748 - $2,242	20 Added 0.67%	3,000 $0
Q3 2022 Oct 11, 2022	BUY	$84.53 - $94.96 $1,521 - $1,709	18 Added 0.61%	2,980 $270,000
Q2 2022 Jul 26, 2022	BUY	$83.49 - $94.64 $1,419 - $1,608	17 Added 0.58%	2,962 $278,000
Q1 2022 Apr 28, 2022	BUY	$73.51 - $82.4 $216,486 - $242,668	2,945 New	2,945 $254,000
Q4 2018 Feb 12, 2019	SELL	$65.24 - $75.71 $60,934 - $70,713	-934 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$57.69 - $67.84 $5,711 - $6,716	-99 Reduced 9.58%	934 $66,000
Q2 2018 Jul 30, 2018	BUY	$50.83 - $59.72 $8,132 - $9,555	160 Added 18.33%	1,033 $63,000
Q1 2018 May 07, 2018	BUY	$50.96 - $59.23 $44,488 - $51,707	873 New	873 $48,000

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballew Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ballew Advisors, Inc with notifications on news.

Account

Ballew Advisors, Inc Merck & Co., Inc. Transaction History